I-Mab (NASDAQ:IMAB) Q4 2022 Earnings Call Transcript

I-Mab (NASDAQ:IMAB) Q4 2022 Earnings Call Transcript March 31, 2023

Tyler Ehler: Good morning to everyone and thank you for joining us this morning. Thank you all for standing by. And I’d like to take this opportunity to welcome you all to the I-Mab BioPharma Full Year 2022 Financial Results and Business Update Conference Call. This is Tyler Ehler here. I-Mab’s Senior Director of Investor Relations. At this time, all participants are in a listen-only mode. At the end of this call, we’ll...